Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary Report

Twenty-nine newly diagnosed individuals with Nonalcoholic Fatty Liver Disease (NAFLD) remaining on habitual dietary regimen were supplemented with regular or lycosome formulations of phosphatidylcholine (PC) during a pilot, randomized, double-blinded clinical study. After two months of oral PC intak...

Descripción completa

Detalles Bibliográficos
Autores principales: Petyaev, Ivan M., Dovgalevsky, Pavel Y., Chalyk, Natalia E., Klochkov, Victor A., Kyle, Nigel H., Bashmakov, Yuriy K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899869/
https://www.ncbi.nlm.nih.gov/pubmed/29805971
http://dx.doi.org/10.1155/2018/4549614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899869/
https://www.ncbi.nlm.nih.gov/pubmed/29805971
http://dx.doi.org/10.1155/2018/4549614

Ejemplares similares